BlackRock Investment Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	$1.06M	Buy	39,133 +4,238	+12%	+$115K	﹤0.01%	2654
2016 Q3	$894K	Buy	34,895 +742	+2%	+$19K	﹤0.01%	2733
2016 Q2	$631K	Buy	34,153 +13,734	+67%	+$254K	﹤0.01%	2915
2016 Q1	$387K	Buy	20,419 +446	+2%	+$8.45K	﹤0.01%	2982
2015 Q4	$538K	Buy	+19,973	New	+$538K	﹤0.01%	2973